Genmab — November 2015
-
https://ash.confex.com/ash/2015/webprogram/Paper79122.html taget herfra selvfølgelig.
-
Conclusions: The addition of DARA to POM-D was well tolerated and did not result in additional toxicities with the exception of DARA-related infusion
reactions. Deep and durable responses were observed quickly, along with a high response rate. Study enrollment is ongoing and data will be updated at the meeting. -
^ det tegner godt for godkendelsen
-
Det må vi formode med den rullende ansøgning.
-
facts er at US tordner ned. Derfor skal vi også ned
-
Alt kan ske i tossetimen
-
-
De er sgu noget byrdefulde at holde fest med, de amerikanere
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind